Global Drug Delivery Systems

Drug Delivery Systems Comprehensive Study by Type (Oral Drug Delivery System, Injection-based Drug Delivery System, Inhalation/Pulmonary Drug Delivery System, Transdermal Drug Delivery System, Trans mucosal Drug Delivery System, Carrier-based Drug Delivery System, Others), Application (Cardiovascular Diseases, Oncology, Urology, Diabetes, CNS, Ophthalmology, Inflammatory Diseases, Infections, Other), Technology (Prodrug, Implants And Intrauterine Devices, Targeted Drug Delivery, Polymeric Drug Delivery, Others) Players and Region - Global Market Outlook to 2026

Drug Delivery Systems Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 6.84%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Drug Delivery System is the combination of traditional drugs delivery methods with engineered technology. It is used to transport medicine to an exact location in the body in the case of cancer, tumor etc. Drug Delivery System market is expected to mark significant growth over forecasted period owing to increasing prevalence of chronic diseases, availability of advanced technology and continuous launch of new products. For Instance, Sun Pharma launched a product which is related to novel drug that beneficial for heart patients in US market. Further, increasing demand for the drug delivery system expected to drive the market growth over the forecasted period.According to AMA, the market for Drug Delivery Systems is expected to register a CAGR of 6.84% during the forecast period to 2026. This growth is primarily driven by Increase Prevalence Of Diseases Boost the Drug Delivery System Market. and Rising Aging Population Fuelled up the Drug Delivery System Market..

Globally, a noticeable market trend is evident Increase in research and developments activities leads to boost the market. . The Health Care Services sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as AstraZeneca plc. (United Kingdom), Bayer AG (Germany), Pfizer, Inc. (United States), Novartis AG (Switzerland), Amgen Inc. (United States), Johnson and Johnson Services, Inc. (United States), Boston Scientific Corporation (United States) and Becton, Dickinson & Company (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In April 2019, Boehringer Ingelheim acquired ICD Therapautics. This acquisition is beneficial in providing robust pipeline for oncology and immune oncology compounds. It also used the ICDs MacroDel technology that enabled the exploitationof transport proteins in the cell membrane that delivers drug candidates inside the tumor cells.

Regulatory Insights:
“According to Pharmaceutical Regulatory Affairs, its act as an important role for approval of generics and the process is also being very stringent in various countries such as United States, Europe, Canada, Australia, and Japan includes standard skin irritation, sensitization and adhesion studies with the patch itself in animals/humans. The production of transdermal drug delivery system medications has increased, because these sorts of systems have proved more effective in many situations at directly sending drugs into the body.”

Market Drivers
  • Increase Prevalence Of Diseases Boost the Drug Delivery System Market.
  • Rising Aging Population Fuelled up the Drug Delivery System Market.

Market Trend
  • Increase in research and developments activities leads to boost the market.
  • Rise in demand of drug delivery system in emerging countries.

Restraints
  • Lack of Skilled and Trained Professional Hampers the Drug Delivery System Market.
  • Dosage Error Leads to Restrain the Market.

Opportunities
Proliferation of Technology Advancements Such as Sigma Spectrum Infusion System Leads to Grow the Drug Delivery System Market. and Upsurge Demand of Novel Drug Delivery System Expected to Boost the Market.
Challenges
Limitation Due to Product Recall are Anticipated to Challenge the Market. and Substitutes Available Such as Nano Medicine-Based Drug Delivery Threat the Drug Delivery System Market.

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Drug Delivery Systems Study Sheds Light on
— The Drug Delivery Systems Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Drug Delivery Systems industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Drug Delivery Systems industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Oral Drug Delivery System
  • Injection-based Drug Delivery System
  • Inhalation/Pulmonary Drug Delivery System
  • Transdermal Drug Delivery System
  • Trans mucosal Drug Delivery System
  • Carrier-based Drug Delivery System
  • Others
By Application
  • Cardiovascular Diseases
  • Oncology
  • Urology
  • Diabetes
  • CNS
  • Ophthalmology
  • Inflammatory Diseases
  • Infections
  • Other
By Technology
  • Prodrug
  • Implants And Intrauterine Devices
  • Targeted Drug Delivery
  • Polymeric Drug Delivery
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase Prevalence Of Diseases Boost the Drug Delivery System Market.
      • 3.2.2. Rising Aging Population Fuelled up the Drug Delivery System Market.
    • 3.3. Market Challenges
      • 3.3.1. Limitation Due to Product Recall are Anticipated to Challenge the Market.
      • 3.3.2. Substitutes Available Such as Nano Medicine-Based Drug Delivery Threat the Drug Delivery System Market.
    • 3.4. Market Trends
      • 3.4.1. Increase in research and developments activities leads to boost the market.
      • 3.4.2. Rise in demand of drug delivery system in emerging countries.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Drug Delivery Systems, by Type, Application, Technology and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Drug Delivery Systems (Value)
      • 5.2.1. Global Drug Delivery Systems by: Type (Value)
        • 5.2.1.1. Oral Drug Delivery System
        • 5.2.1.2. Injection-based Drug Delivery System
        • 5.2.1.3. Inhalation/Pulmonary Drug Delivery System
        • 5.2.1.4. Transdermal Drug Delivery System
        • 5.2.1.5. Trans mucosal Drug Delivery System
        • 5.2.1.6. Carrier-based Drug Delivery System
        • 5.2.1.7. Others
      • 5.2.2. Global Drug Delivery Systems by: Application (Value)
        • 5.2.2.1. Cardiovascular Diseases
        • 5.2.2.2. Oncology
        • 5.2.2.3. Urology
        • 5.2.2.4. Diabetes
        • 5.2.2.5. CNS
        • 5.2.2.6. Ophthalmology
        • 5.2.2.7. Inflammatory Diseases
        • 5.2.2.8. Infections
        • 5.2.2.9. Other
      • 5.2.3. Global Drug Delivery Systems by: Technology (Value)
        • 5.2.3.1. Prodrug
        • 5.2.3.2. Implants And Intrauterine Devices
        • 5.2.3.3. Targeted Drug Delivery
        • 5.2.3.4. Polymeric Drug Delivery
        • 5.2.3.5. Others
      • 5.2.4. Global Drug Delivery Systems Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Drug Delivery Systems (Price)
      • 5.3.1. Global Drug Delivery Systems by: Type (Price)
  • 6. Drug Delivery Systems: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. AstraZeneca plc. (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bayer AG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pfizer, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Novartis AG (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Amgen Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Johnson and Johnson Services, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Boston Scientific Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Becton, Dickinson & Company (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Drug Delivery Systems Sale, by Type, Application, Technology and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Drug Delivery Systems (Value)
      • 7.2.1. Global Drug Delivery Systems by: Type (Value)
        • 7.2.1.1. Oral Drug Delivery System
        • 7.2.1.2. Injection-based Drug Delivery System
        • 7.2.1.3. Inhalation/Pulmonary Drug Delivery System
        • 7.2.1.4. Transdermal Drug Delivery System
        • 7.2.1.5. Trans mucosal Drug Delivery System
        • 7.2.1.6. Carrier-based Drug Delivery System
        • 7.2.1.7. Others
      • 7.2.2. Global Drug Delivery Systems by: Application (Value)
        • 7.2.2.1. Cardiovascular Diseases
        • 7.2.2.2. Oncology
        • 7.2.2.3. Urology
        • 7.2.2.4. Diabetes
        • 7.2.2.5. CNS
        • 7.2.2.6. Ophthalmology
        • 7.2.2.7. Inflammatory Diseases
        • 7.2.2.8. Infections
        • 7.2.2.9. Other
      • 7.2.3. Global Drug Delivery Systems by: Technology (Value)
        • 7.2.3.1. Prodrug
        • 7.2.3.2. Implants And Intrauterine Devices
        • 7.2.3.3. Targeted Drug Delivery
        • 7.2.3.4. Polymeric Drug Delivery
        • 7.2.3.5. Others
      • 7.2.4. Global Drug Delivery Systems Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Drug Delivery Systems (Price)
      • 7.3.1. Global Drug Delivery Systems by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Drug Delivery Systems: by Type(USD Billion)
  • Table 2. Drug Delivery Systems Oral Drug Delivery System , by Region USD Billion (2015-2020)
  • Table 3. Drug Delivery Systems Injection-based Drug Delivery System , by Region USD Billion (2015-2020)
  • Table 4. Drug Delivery Systems Inhalation/Pulmonary Drug Delivery System , by Region USD Billion (2015-2020)
  • Table 5. Drug Delivery Systems Transdermal Drug Delivery System , by Region USD Billion (2015-2020)
  • Table 6. Drug Delivery Systems Trans mucosal Drug Delivery System , by Region USD Billion (2015-2020)
  • Table 7. Drug Delivery Systems Carrier-based Drug Delivery System , by Region USD Billion (2015-2020)
  • Table 8. Drug Delivery Systems Others , by Region USD Billion (2015-2020)
  • Table 9. Drug Delivery Systems: by Application(USD Billion)
  • Table 10. Drug Delivery Systems Cardiovascular Diseases , by Region USD Billion (2015-2020)
  • Table 11. Drug Delivery Systems Oncology , by Region USD Billion (2015-2020)
  • Table 12. Drug Delivery Systems Urology , by Region USD Billion (2015-2020)
  • Table 13. Drug Delivery Systems Diabetes , by Region USD Billion (2015-2020)
  • Table 14. Drug Delivery Systems CNS , by Region USD Billion (2015-2020)
  • Table 15. Drug Delivery Systems Ophthalmology , by Region USD Billion (2015-2020)
  • Table 16. Drug Delivery Systems Inflammatory Diseases , by Region USD Billion (2015-2020)
  • Table 17. Drug Delivery Systems Infections , by Region USD Billion (2015-2020)
  • Table 18. Drug Delivery Systems Other , by Region USD Billion (2015-2020)
  • Table 19. Drug Delivery Systems: by Technology(USD Billion)
  • Table 20. Drug Delivery Systems Prodrug , by Region USD Billion (2015-2020)
  • Table 21. Drug Delivery Systems Implants And Intrauterine Devices , by Region USD Billion (2015-2020)
  • Table 22. Drug Delivery Systems Targeted Drug Delivery , by Region USD Billion (2015-2020)
  • Table 23. Drug Delivery Systems Polymeric Drug Delivery , by Region USD Billion (2015-2020)
  • Table 24. Drug Delivery Systems Others , by Region USD Billion (2015-2020)
  • Table 25. South America Drug Delivery Systems, by Country USD Billion (2015-2020)
  • Table 26. South America Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 27. South America Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 28. South America Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 29. Brazil Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 30. Brazil Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 31. Brazil Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 32. Argentina Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 33. Argentina Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 34. Argentina Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 35. Rest of South America Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 36. Rest of South America Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 37. Rest of South America Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 38. Asia Pacific Drug Delivery Systems, by Country USD Billion (2015-2020)
  • Table 39. Asia Pacific Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 40. Asia Pacific Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 41. Asia Pacific Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 42. China Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 43. China Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 44. China Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 45. Japan Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 46. Japan Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 47. Japan Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 48. India Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 49. India Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 50. India Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 51. South Korea Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 52. South Korea Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 53. South Korea Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 54. Taiwan Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 55. Taiwan Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 56. Taiwan Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 57. Australia Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 58. Australia Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 59. Australia Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 60. Rest of Asia-Pacific Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 61. Rest of Asia-Pacific Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 62. Rest of Asia-Pacific Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 63. Europe Drug Delivery Systems, by Country USD Billion (2015-2020)
  • Table 64. Europe Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 65. Europe Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 66. Europe Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 67. Germany Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 68. Germany Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 69. Germany Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 70. France Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 71. France Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 72. France Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 73. Italy Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 74. Italy Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 75. Italy Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 76. United Kingdom Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 77. United Kingdom Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 78. United Kingdom Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 79. Netherlands Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 80. Netherlands Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 81. Netherlands Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 82. Rest of Europe Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 83. Rest of Europe Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 84. Rest of Europe Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 85. MEA Drug Delivery Systems, by Country USD Billion (2015-2020)
  • Table 86. MEA Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 87. MEA Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 88. MEA Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 89. Middle East Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 90. Middle East Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 91. Middle East Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 92. Africa Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 93. Africa Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 94. Africa Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 95. North America Drug Delivery Systems, by Country USD Billion (2015-2020)
  • Table 96. North America Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 97. North America Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 98. North America Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 99. United States Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 100. United States Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 101. United States Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 102. Canada Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 103. Canada Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 104. Canada Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 105. Mexico Drug Delivery Systems, by Type USD Billion (2015-2020)
  • Table 106. Mexico Drug Delivery Systems, by Application USD Billion (2015-2020)
  • Table 107. Mexico Drug Delivery Systems, by Technology USD Billion (2015-2020)
  • Table 108. Drug Delivery Systems: by Type(USD/Units)
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Company Basic Information, Sales Area and Its Competitors
  • Table 116. Company Basic Information, Sales Area and Its Competitors
  • Table 117. Drug Delivery Systems: by Type(USD Billion)
  • Table 118. Drug Delivery Systems Oral Drug Delivery System , by Region USD Billion (2021-2026)
  • Table 119. Drug Delivery Systems Injection-based Drug Delivery System , by Region USD Billion (2021-2026)
  • Table 120. Drug Delivery Systems Inhalation/Pulmonary Drug Delivery System , by Region USD Billion (2021-2026)
  • Table 121. Drug Delivery Systems Transdermal Drug Delivery System , by Region USD Billion (2021-2026)
  • Table 122. Drug Delivery Systems Trans mucosal Drug Delivery System , by Region USD Billion (2021-2026)
  • Table 123. Drug Delivery Systems Carrier-based Drug Delivery System , by Region USD Billion (2021-2026)
  • Table 124. Drug Delivery Systems Others , by Region USD Billion (2021-2026)
  • Table 125. Drug Delivery Systems: by Application(USD Billion)
  • Table 126. Drug Delivery Systems Cardiovascular Diseases , by Region USD Billion (2021-2026)
  • Table 127. Drug Delivery Systems Oncology , by Region USD Billion (2021-2026)
  • Table 128. Drug Delivery Systems Urology , by Region USD Billion (2021-2026)
  • Table 129. Drug Delivery Systems Diabetes , by Region USD Billion (2021-2026)
  • Table 130. Drug Delivery Systems CNS , by Region USD Billion (2021-2026)
  • Table 131. Drug Delivery Systems Ophthalmology , by Region USD Billion (2021-2026)
  • Table 132. Drug Delivery Systems Inflammatory Diseases , by Region USD Billion (2021-2026)
  • Table 133. Drug Delivery Systems Infections , by Region USD Billion (2021-2026)
  • Table 134. Drug Delivery Systems Other , by Region USD Billion (2021-2026)
  • Table 135. Drug Delivery Systems: by Technology(USD Billion)
  • Table 136. Drug Delivery Systems Prodrug , by Region USD Billion (2021-2026)
  • Table 137. Drug Delivery Systems Implants And Intrauterine Devices , by Region USD Billion (2021-2026)
  • Table 138. Drug Delivery Systems Targeted Drug Delivery , by Region USD Billion (2021-2026)
  • Table 139. Drug Delivery Systems Polymeric Drug Delivery , by Region USD Billion (2021-2026)
  • Table 140. Drug Delivery Systems Others , by Region USD Billion (2021-2026)
  • Table 141. South America Drug Delivery Systems, by Country USD Billion (2021-2026)
  • Table 142. South America Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 143. South America Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 144. South America Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 145. Brazil Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 146. Brazil Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 147. Brazil Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 148. Argentina Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 149. Argentina Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 150. Argentina Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 151. Rest of South America Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 152. Rest of South America Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 153. Rest of South America Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 154. Asia Pacific Drug Delivery Systems, by Country USD Billion (2021-2026)
  • Table 155. Asia Pacific Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 156. Asia Pacific Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 157. Asia Pacific Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 158. China Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 159. China Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 160. China Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 161. Japan Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 162. Japan Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 163. Japan Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 164. India Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 165. India Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 166. India Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 167. South Korea Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 168. South Korea Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 169. South Korea Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 170. Taiwan Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 171. Taiwan Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 172. Taiwan Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 173. Australia Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 174. Australia Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 175. Australia Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 176. Rest of Asia-Pacific Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 177. Rest of Asia-Pacific Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 178. Rest of Asia-Pacific Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 179. Europe Drug Delivery Systems, by Country USD Billion (2021-2026)
  • Table 180. Europe Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 181. Europe Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 182. Europe Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 183. Germany Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 184. Germany Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 185. Germany Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 186. France Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 187. France Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 188. France Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 189. Italy Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 190. Italy Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 191. Italy Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 192. United Kingdom Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 193. United Kingdom Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 194. United Kingdom Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 195. Netherlands Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 196. Netherlands Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 197. Netherlands Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 198. Rest of Europe Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 199. Rest of Europe Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 200. Rest of Europe Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 201. MEA Drug Delivery Systems, by Country USD Billion (2021-2026)
  • Table 202. MEA Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 203. MEA Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 204. MEA Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 205. Middle East Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 206. Middle East Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 207. Middle East Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 208. Africa Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 209. Africa Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 210. Africa Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 211. North America Drug Delivery Systems, by Country USD Billion (2021-2026)
  • Table 212. North America Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 213. North America Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 214. North America Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 215. United States Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 216. United States Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 217. United States Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 218. Canada Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 219. Canada Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 220. Canada Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 221. Mexico Drug Delivery Systems, by Type USD Billion (2021-2026)
  • Table 222. Mexico Drug Delivery Systems, by Application USD Billion (2021-2026)
  • Table 223. Mexico Drug Delivery Systems, by Technology USD Billion (2021-2026)
  • Table 224. Drug Delivery Systems: by Type(USD/Units)
  • Table 225. Research Programs/Design for This Report
  • Table 226. Key Data Information from Secondary Sources
  • Table 227. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Drug Delivery Systems: by Type USD Billion (2015-2020)
  • Figure 5. Global Drug Delivery Systems: by Application USD Billion (2015-2020)
  • Figure 6. Global Drug Delivery Systems: by Technology USD Billion (2015-2020)
  • Figure 7. South America Drug Delivery Systems Share (%), by Country
  • Figure 8. Asia Pacific Drug Delivery Systems Share (%), by Country
  • Figure 9. Europe Drug Delivery Systems Share (%), by Country
  • Figure 10. MEA Drug Delivery Systems Share (%), by Country
  • Figure 11. North America Drug Delivery Systems Share (%), by Country
  • Figure 12. Global Drug Delivery Systems: by Type USD/Units (2015-2020)
  • Figure 13. Global Drug Delivery Systems share by Players 2020 (%)
  • Figure 14. Global Drug Delivery Systems share by Players (Top 3) 2020(%)
  • Figure 15. Global Drug Delivery Systems share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. AstraZeneca plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 18. AstraZeneca plc. (United Kingdom) Revenue: by Geography 2020
  • Figure 19. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Bayer AG (Germany) Revenue: by Geography 2020
  • Figure 21. Pfizer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Pfizer, Inc. (United States) Revenue: by Geography 2020
  • Figure 23. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 24. Novartis AG (Switzerland) Revenue: by Geography 2020
  • Figure 25. Amgen Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Amgen Inc. (United States) Revenue: by Geography 2020
  • Figure 27. Johnson and Johnson Services, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Johnson and Johnson Services, Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Boston Scientific Corporation (United States) Revenue: by Geography 2020
  • Figure 31. Becton, Dickinson & Company (United States) Revenue, Net Income and Gross profit
  • Figure 32. Becton, Dickinson & Company (United States) Revenue: by Geography 2020
  • Figure 33. Global Drug Delivery Systems: by Type USD Billion (2021-2026)
  • Figure 34. Global Drug Delivery Systems: by Application USD Billion (2021-2026)
  • Figure 35. Global Drug Delivery Systems: by Technology USD Billion (2021-2026)
  • Figure 36. South America Drug Delivery Systems Share (%), by Country
  • Figure 37. Asia Pacific Drug Delivery Systems Share (%), by Country
  • Figure 38. Europe Drug Delivery Systems Share (%), by Country
  • Figure 39. MEA Drug Delivery Systems Share (%), by Country
  • Figure 40. North America Drug Delivery Systems Share (%), by Country
  • Figure 41. Global Drug Delivery Systems: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • AstraZeneca plc. (United Kingdom)
  • Bayer AG (Germany)
  • Pfizer, Inc. (United States)
  • Novartis AG (Switzerland)
  • Amgen Inc. (United States)
  • Johnson and Johnson Services, Inc. (United States)
  • Boston Scientific Corporation (United States)
  • Becton, Dickinson & Company (United States)
Additional players considered in the study are as follows:
Abbott Laboratories (United States) , 3M (United States) , Glaxo Smith Kline PLC (United Kingdom) , Roche (Switzerland)
Select User Access Type

Key Highlights of Report


Sep 2021 210 Pages 97 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Drug Delivery Systems Quantitative research analysis
Global Drug Delivery Systems Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Drug Delivery Systems market is expected to see a CAGR of 6.84% during projected year 2020 to 2026.
Top performing companies in the Global Drug Delivery Systems market are AstraZeneca plc. (United Kingdom), Bayer AG (Germany), Pfizer, Inc. (United States), Novartis AG (Switzerland), Amgen Inc. (United States), Johnson and Johnson Services, Inc. (United States), Boston Scientific Corporation (United States) and Becton, Dickinson & Company (United States), to name a few.
North America is dominating the Drug Delivery Systems Market.

Know More About Global Drug Delivery Systems Report?

Have a Query? Click Here

Other Related Reports

Topical Hair Loss Treatments Comprehensive Study by Type (Minoxidil Solution, Herbal Extract Treatment, Other), Application (Male, Female), Distribution Channel (Offline, Online) Players and Region -...
$ 3500
Weight Loss Management Comprehensive Study by Type (Weight Loss Diet, Fitness Equipment, Surgical Equipment), Application (Fitness Centers, Slimming Centers, Consulting Services, Online Weight Loss P...
$ 3350
Neonatal Intensive Care Comprehensive Study by Type (Infant Warmers, Incubators, Convertible Warmer & Incubators, Neonatal Monitoring Devices, Respiratory Devices, Phototherapy Equipment, Others), Ap...
$ 3750
Pharmaceutical Testing Services Comprehensive Study by Testing Service (Bioanalytical Testing, Method Development & Validation, Raw Materials Testing, API Quality Control, In-Process and Product Rele...
$ 3650
Laboratory Informatics Comprehensive Study by Type (Laboratory Information Management Systems, Electronic Lab Notebooks, Scientific Data Management Systems, Laboratory Execution Systems, Chromatograp...
$ 3750
Teleradiology Services Comprehensive Study by Application (Radiology Information System (RIS), Picture Archiving and Communication System (PACS), Integrated (RIS and PACS), Others), Services (General...
$ 3750